Voloridge Investment Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.4M | Sell |
|
|||||
|
2025
Q1 | $53.9M | Buy |
|
|||||
|
2024
Q4 | $41.2M | Sell |
|
|||||
|
2024
Q3 | $59.3M | Buy |
|
|||||
|
2024
Q2 | $47.2M | Buy |
|
|||||
|
2024
Q1 | $46.5M | Buy |
|
|||||
|
2023
Q4 | $9.24M | Buy |
|
|||||
|
2023
Q3 | $1.86M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $221K | Sell |
|
|||||
|
2021
Q4 | $627K | Sell |
|
|||||
|
2021
Q3 | $1.01M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $937K | Sell |
|
|||||
|
2020
Q3 | $1.09M | Buy |
|
|||||
|
2020
Q2 | $1.03M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $4.7M | Buy |
|
|||||
|
2019
Q3 | $2.35M | Buy |
|
|||||
|
2019
Q2 | $238K | Sell |
|
|||||
|
2019
Q1 | $808K | Buy |
|